Basecamp Wealth Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.35K Sell
22
-49
-69% -$5.93K ﹤0.01% 1329
2026
Q1
$11.6K Buy
71
+23
+48% +$3.54K ﹤0.01% 983
2025
Q4
$8.35K Buy
+48
New +$8.76K ﹤0.01% 1023

Other funds holding INSM

Basecamp Wealth Advisors's INSM Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its Insmed (INSM) stake by 69% in Q2 2026, selling an estimated $5.93K and leaving 22 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1329.

Basecamp Wealth Advisors first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.6K in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Basecamp Wealth Advisors held 22 shares of Insmed worth $2.35K as of Q2 2026.
  • Basecamp Wealth Advisors sold 49 Insmed shares in Q2 2026, an estimated $5.93K.
  • Insmed made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1329 holding.
  • Basecamp Wealth Advisors first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Insmed position peaked at $11.6K in Q1 2026.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.